Vivitrol 380 MG vial-diluents
Ended Awarded
- Contract number
- SPE2DB25FQ91G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,191
Award facts
- Contract value 100% obligated
- $6,190.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Vivitrol 380 mg vial-diluents, with a ceiling value of $6,190.54. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2026 that serves as the company's primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of federal contracts with the Defense Logistics Agency Medical Supply Chain, demonstrating capability in supplying diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The delivery order for Vivitrol, an extended-release naltrexone formulation used in opioid dependence treatment, exemplifies the company's role in supporting Defense Health Agency and military medical operations through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FQ91G?
SPE2DB25FQ91G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FQ91G worth?
The government has obligated $6,191 on SPE2DB25FQ91G.
Is contract SPE2DB25FQ91G an order under another contract?
Yes. SPE2DB25FQ91G is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ91G competed?
The extent of competition for SPE2DB25FQ91G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award